University of Central Arkansas
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, University of Central Arkansas sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
University of Central Arkansas: 3 sponsored US clinical trials, none currently recruiting.
University of Central Arkansas sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Diabetes Mellitus, Type 2, with 1 trials.
Upper-quartile sponsor footprint
University of Central Arkansas sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Single-blind RCT Comparing Smartphone vs. Paper-based HEP in Pelvic Floor PT
NCT06162845
The Effect of Exercise Training Intensity in Patients With Type 2 Diabetes
NCT01417845
The Impact of Exercise Counseling on Exercise Behavior in People With Type 2 Diabetes: A Randomized Clinical Trial
NCT00910507
Therapeutic Areas
How the University of Central Arkansas archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Diabetes Mellitus, Type 2 (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
University of Central Arkansas: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
University of Central Arkansas sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this University of Central Arkansas page
3 registered trials is a research-attention snapshot, not an endorsement of University of Central Arkansas or any single study.
- None of University of Central Arkansas's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Diabetes Mellitus, Type 2 is the condition University of Central Arkansas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetes Mellitus, Type 2 trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Central Arkansas pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.